MICROPURE GENOMICS INC.

SBIR Phase II: Rapid, End-to-end Sample Preparation for Sequencing Applications

Operating in biomedical eng and diagnostics, exp prog to stim comp res based in SAN DIEGO, CA, MICROPURE GENOMICS INC. was founded in 2021.

Profile

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of an innovative platform for preparing DNA samples for long-read sequencing technologies. These technologies offer unprecedented insights into complex genetic structures and their connections to health and disease but require long, continuous DNA strands for optimal performance. Current sample preparation methods are labor-intensive and expensive, and often compromise DNA quality and length, limiting the utility and adoption of long-read sequencers. This project’s automated platform will deliver high quality DNA samples with improved reproducibility, reduced preparation time, and lower costs. Beyond advancing long-read sequencing, the platform will also support DNA preparation for other sequencing (next-generation sequencing) and analytical methods, broadening its impact. The sequencing sample preparation market is a large and rapidly growing market (annual growth rate of 13.4%), with long-read sequencing currently comprising ~10% of the total market. By overcoming critical barriers, this innovation will accelerate the adoption of long-read sequencing, drive market growth, and contribute to improved health outcomes through enhanced diagnostics and research capabilities.

This Small Business Innovation Research (SBIR) Phase II project aims to resolve a

Its activity falls under biomedical eng and diagnostics, exp prog to stim comp res; the profile below is assembled from public directory data.

The business is associated with SAN DIEGO, CA.

It is recorded at the SBIR Phase II stage.

Its team size is recorded as 1-10 employees.

It has disclosed roughly $1.3M in funding.

Website: micropuregenomics.com